Glukanmedsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2018-07-31
Share capital
5,000.00 PLN
Registered address
ul. Aleja T. Kościuszki 80/82/301, 90-437 Łódź, Poland
Electronic delivery address
AE:PL-10760-68606-WWFDW-37

Financials

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 90 days for 2021).

  • 202516/07/2026
  • 202413/07/2025
  • 202313/07/2024
  • 202215/07/2023
  • 202113/10/2022
  • 202030/09/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Scientific research and development1,565 / 1,953
Top 80%
City · Łódź7,234 / 8,064
Top 90%
Voivodeship · Łódzkie13,943 / 15,300
Top 91%
Country · Poland269,943 / 297,873
Top 91%

Results vs industry

Revenue
This companyUSD 3.80kMedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD 2.66kMedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 1.14kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 21.79kMedianUSD 133.19kAverageUSD 3.03m

Authorized Representatives

Maciej Mirosław Schabowski – Management Board Member
Zuzanna Weronika Przekop – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Mariusz Tomasz Chudzickiage 57
20$270.1220%
Piotr Frydrychage 41
24$324.1524%
Zuzanna Weronika Przekopage 32
28$378.1728%
Maciej Mirosław Schabowskiage 44
28$378.1728%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2018-08-11.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $178,173.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$109.4K
Aid for SMEs for innovation support
$57,972

European Funds

ProjectEU co-financing
Designing a formulation for an emulsion with beta-glucan obtained from oats and designing patches containing it.
$167.3K

Competitors

Name
Proteon PharmaceuticalsS.A.
Centrum Badań Weterynaryjnych Vetcomplexsp. z o.o.
UveraS.A.
Luna Laboratorysp. z o.o.
Fusiomicasp. z o.o.
Poltisssp. z o.o.
Omnisepticasp. z o.o.
Plan Biosp. z o.o.
Greenetoxsp. z o.o.
Passio Human Microbiomesp. z o.o.

Change history

DateEvent
2018-10-25Address change
2018-07-31Entered in the register

FAQ

Last updated: 2026-07-16